Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois.
Robert H. Lurie Comprehensive Cancer Center, Division of Hematology and Medical Oncology, Northwestern University, Chicago, Illinois.
JAMA Netw Open. 2020 Mar 2;3(3):e200708. doi: 10.1001/jamanetworkopen.2020.0708.
Women are underrepresented in medical leadership positions; however, representation of women among academic oncology leadership is unknown.
To evaluate representation of women overall and in leadership positions in academic medical oncology (MO), radiation oncology (RO), and surgical oncology (SO) programs and to examine the association of women leadership with overall faculty representation of women per program.
DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, MO, RO, and SO training program websites were queried from October 2018 through June 2019. All faculty from 265 of 273 accredited MO, RO, and SO training programs (97.1%) were included.
Gender.
Observed proportions of women in leadership positions compared with the expected proportion of overall women faculty in MO, RO, and SO were assessed. Rates of representation of women across each MO, RO, and SO program's faculty based on the presence or absence of a woman in a leadership position were compared.
Of 6030 total faculty, only 2164 (35.9%) were women. Total representation of women among MO, RO, and SO faculty was 37.1% (1563 of 4215), 30.7% (389 of 1269), and 38.8% (212 of 546), respectively. Women composed only 21.7% (30 of 138), 11.7% (11 of 94), and 3.8% (1 of 26) of MO, RO, and SO chair positions, respectively. The observed proportion of women in chair positions was significantly lower than the expected proportion for MO, RO, and SO. In all, 47.9%, 33%, and 18.5% of MO, RO, and SO programs, respectively, had at least 1 woman in a leadership position (program director or chair). Programs with 1 or more women in a leadership position were associated with a higher mean (SD) percentage of women faculty than those without at least 1 woman leader in MO (40.7% [12.5%] vs 33.1% [11.0%]; P < .001) and RO (36.2% [13.3%] vs 23.4% [12.3%]; P < .001) but not SO (40.2% [15.4%] vs 31.4% [16.9%]; P = .29).
Gender disparity exists in academic MO, RO, and SO faculty, which is magnified at the chair level. Programs in MO and RO with a woman physician in a leadership position were associated with a higher percentage of women faculty, but this was not true for SO. These data will serve as a benchmark to monitor progress toward a more balanced workforce.
女性在医学领导岗位上的代表性不足;然而,学术肿瘤学领导岗位中的女性代表情况尚不清楚。
评估女性在医学肿瘤学(MO)、放射肿瘤学(RO)和外科肿瘤学(SO)项目中的整体和领导职位中的代表性,并研究女性领导在每个项目中的女性教员总体代表性中的关联。
设计、设置和参与者:在这项横断面研究中,从 2018 年 10 月到 2019 年 6 月,查询了 273 个 MO、RO 和 SO 培训项目中的 265 个培训项目网站。纳入了所有 273 个 MO、RO 和 SO 培训项目中 97.1%(265 个中的 263 个)的教员。
性别。
评估了 MO、RO 和 SO 中领导职位中的女性比例与 MO、RO 和 SO 中女性教员总数的预期比例之间的差异。比较了基于领导职位中是否有女性,每个 MO、RO 和 SO 项目的教员中女性的代表性。
在总共 6030 名教员中,只有 2164 名(35.9%)是女性。MO、RO 和 SO 教员中的女性总代表性分别为 37.1%(4215 人中有 1563 人)、30.7%(1269 人中有 389 人)和 38.8%(212 人中有 212 人)。MO、RO 和 SO 的主席职位中仅有 21.7%(138 人中有 30 人)、11.7%(94 人中有 11 人)和 3.8%(26 人中有 1 人)是女性。MO、RO 和 SO 主席职位中的女性观察到的比例明显低于预期。在 MO、RO 和 SO 中,分别有 47.9%、33%和 18.5%的项目至少有 1 名女性担任领导职务(项目主任或主席)。有 1 名或更多女性担任领导职务的项目与女性教员的平均(SD)百分比较高相关,而没有至少 1 名女性领导的项目在 MO(40.7%[12.5%]与 33.1%[11.0%];P<.001)和 RO(36.2%[13.3%]与 23.4%[12.3%];P<.001)中,而在 SO 中则不然(40.2%[15.4%]与 31.4%[16.9%];P=.29)。
MO、RO 和 SO 教员中存在性别差异,在主席职位上更为明显。在 MO 和 RO 中,有女性医生担任领导职务的项目与女性教员的比例较高相关,但 SO 并非如此。这些数据将作为一个基准,用于监测向更平衡的劳动力发展的进展。